Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.

Hele tekst

(1)Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.. Citation Scholte, A. J. H. A. (2009, November 19). Cardiac imaging for risk stratification in asymptomatic diabetes. Retrieved from https://hdl.handle.net/1887/14368 Version:. Corrected Publisher’s Version. License:. Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded from:. https://hdl.handle.net/1887/14368. Note: To cite this publication please use the final published version (if applicable)..

(2) Chapter. 2.

(3)

(4)

(5) with type 2 diabetes mellitus for silent coronary artery disease. Combined use of

(6)

(7)

(8)

(9)

(10)

(11) .

(12)

(13) . J Nucl Cardiol 2006;13:11-18.

(14) Chapter 2. Abstract

(15)

(16)

(17).

(18)

(19)

(20)

(21) !

(22) "

(23) " # $

(24) %$

(25) & $

(26) '

(27)

(28)

(29).

(30)

(31) %"

(32)

(33)

(34)

(35)

(36)

(37)

(38)

(39)

(40)

(41) %

(42)

(43)

(44)

(45)

(46) $$ $

(47)

(48)

(49)

(50)

(51)

(52)

(53) $ " " #

(54) % !

(55)

(56) $ $

(57) #

(58)

(59) #

(60) &

(61) #

(62) . $

(63) #

(64)

(65) "

(66)

(67)

(68)

(69) $ # &

(70)

(71) '() '*) + "$ $

(72)

(73) $

(74) & ,

(75) .

(76) %

(77)

(78)

(79) %$ $ +

(80) $ "#

(81) &

(82)

(83) #

(84)

(85) "

(86)

(87) $

(88) " imaging and coronary calcium scoring are examined. The two methodologies appear to #

(89) $

(90)

(91) #

(92) "

(93)

(94)

(95) % "$ # &

(96)

(97)

(98).

(99)

(100) % % # #%

(101) 3

(102)

(103) " %

(104) 3

(105)

(106)

(107) $

(108) " %%$ $

(109) . 20.

(110) Screening for silent CAD.

(111) $

(112) #

(113)

(114) "

(115)

(116)

(117).

(118)

(119)

(120) $

(121) $ $

(122) 5 $

(123) $

(124) &

(125) 6

(126) '((. #

(127)

(128) $

(129)

(130)

(131)

(132)

(133) $

(134) .

(135) $ $ %

(136)

(137)

(138)

(139) "

(140)

(141)

(142)

(143)

(144) % 3 +

(145) 7

(146)

(147) 1.3 million individuals are diagnosed with diabetes each year.16 : # $ %

(148)

(149)

(150) ;:<

(151)

(152)

(153) % causes of morbidity and mortality in individuals with type 2 diabetes mellitus.6 The over. $

(154) #

(155)

(156) ":

(157)

(158)

(159) $

(160)

(161) %=()$

(162) &

(163)

(164)

(165) "

(166)

(167) "

(168)

(169) % 17

(170) ?(@

(171)

(172) $

(173) & &: diabetes exceeds 70%.7 Some studies suggest that the risk for future cardiac deaths in $

(174) &

(175)

(176) & &: @

(177) $

(178) & #

(179) : 7+

(180)

(181)

(182) "

(183) $

(184) &

(185)

(186)

(187) &

(188)

(189) "

(190)

(191) $

(192)

(193) $ $

(194) $

(195)

(196) B

(197) $ $

(198) &

(199)

(200)

(201). :"

(202) 3

(203) #

(204)

(205) &

(206)

(207)

(208) . manifest.8, 9:

(209) $%B%$

(210) &

(211)

(212)

(213)

(214) & to improve the survival rate and may be superior to percutaneous coronary interven $

(215)

(216) $

(217)

(218)

(219) "

(220) 6

(221)

(222)

(223) 9 Moreover, the need "

(224) $

(225)

(226) $

(227)

(228)

(229) #

(230)

(231) $%B% %F %

(232)

(233) $

(234) &

(235)

(236) $

(237)

(238) $

(239) 18

(240) $

(241) #

(242)

(243) #

(244)

(245)

(246) $

(247) &

(248)

(249)

(250)

(251)

(252)

(253)

(254)

(255) #

(256) $$ $$

(257) "

(258)

(259) %:

(260) %

(261)

(262) "

(263) $ #

(264)

(265)

(266) " ##

(267)

(268)

(269) #

(270)

(271)

(272) myocardial ischemia: exercise electrocardiography, stress myocardial perfusion imaging ;HI+<

(273)

(274) %$ J

(275) ##

(276)

(277) 3

(278)

(279)

(280)

(281)

(282)

(283) %

(284)

(285) K

(286) $

(287) "

(288)

(289)

(290)

(291) %% "

(292) #

(293)

(294) &. "

(295)

(296) # %@

(297)

(298) ;::< %# $

(299) %$;:< +

(300)

(301) &

(302)

(303) "

(304) $$

(305) "

(306)

(307) %

(308)

(309) "

(310)

(311)

(312)

(313) ":$

(314) "

(315)

(316) #

(317)

(318) # K "

(319) +

(320) $ "#

(321) &&

(322) &. "

(323) $

(324) roles of stress MPI and CT CAC scoring as two complementary approaches for screening $ $

(325) &

(326)

(327) +

(328) "

(329) #

(330)

(331) #

(332)

(333)

(334)

(335)

(336) &

(337) $ $

(338) $

(339) % " $$

(340) 21.

(341) Chapter 2.

(342)

(343)

(344) %

(345)

(346) "

(347) HI+" F &

(348).

(349)

(350)

(351) %

(352)

(353) $ $

(354)

(355) #

(356)

(357) $

(358) &

(359)

(360)

(361).

(362) #

(363)

(364)

(365)

(366)

(367) %%

(368) %$

(369) #

(370)

(371) " HI+

(372)

(373) $

(374) ;

(375) ?< Q

(376). &

(377) %

(378)

(379)

(380) %$

(381) #

(382)

(383) &

(384) $

(385)

(386) "

(387) $

(388)

(389) R

(390) %

(391) "

(392) I

(393) &

(394)

(395) & $

(396)

(397)

(398) &

(399) "

(400) %F %

(401)

(402)

(403) ;*?)< " HI+ $

(404) & $

(405) "%;UU)< 19$ $

(406) &

(407)

(408) %F %

(409)

(410) #

(411)

(412) $

(413) &

(414)

(415) V

(416)

(417) #

(418)

(419)

(420) #

(421)

(422)

(423) $

(424) & W =) $

(425) U *) @

(426) $

(427) 20 As in the general popula

(428) HI+

(429) "$

(430) &

(431)

(432) %@ &@$ % % $ ;

(433) ?<

(434)

(435) #

(436)

(437) " %#

(438) HI+ & %

(439)

(440) $

(441)

(442) $

(443) %%" X =) ?X '

(444) &

(445)

(446) &

(447) H

(448) #

(449) $

(450) &

(451)

(452) HI+ %

(453)

(454) #

(455)

(456)

(457) $

(458) %%" ( Y) X =) Z

(459)

(460) "$

(461) &

(462)

(463) HI+ "#

(464) $

(465) &

(466)

(467) ;[?)<

(468) ,&

(469)

(470) .$

(471) " HI+$$

(472) to be shorter than 2 years.20+

(473) #

(474)

(475) \

(476)

(477)

(478)

(479) $ %

(480) "

(481)

(482)

(483)

(484)

(485).

(486)

(487)

(488)

(489) Z

(490)

(491)

(492) $

(493) ?]]( *Y) "$ $

(494) &

(495)

(496)

(497). $

(498) $

(499) #

(500)

(501)

(502) #

(503)

(504) "

(505) :

(506) HI+ 26 A number "

(507) 3

(508)

(509) #

(510) F

(511)

(512) $

(513)

(514)

(515) "

(516)

(517) $ $

(518) &

(519)

(520) 19, 25-38 The reported prevalence of silent ischemia, however, varied markedly between studies, from 6% to 59%.19, 30, 34, 36, 38-40 This wide range in the $

(521) #

(522)

(523) "

(524)

(525)

(526)

(527)

(528) 6

(529)

(530)

(531) $

(532)

(533)

(534)

(535)

(536) % %%

(537) 3

(538)

(539) $

(540) #

(541)

(542) F !

(543) #

(544) &%

(545) #

(546)

(547)

(548)

(549)

(550) %$ $

(551) &

(552)

(553)

(554) %X $

(555) "

(556) ;

(557) '<R;<

(558) $

(559) #

(560)

(561)

(562) "$

(563)

(564) "

(565)

(566) "

(567)

(568) %&

(569)

(570) ;<

(571) $

(572) #

(573)

(574)

(575) " &$ $

(576) &

(577)

(578)

(579) "

(580)

(581) "

(582)

(583) % ;:< $ $

(584) #

(585)

(586) $ $

(587) &

(588)

(589)

(590)

(591) "

(592)

(593) 22.

(594) Screening for silent CAD. Table 1. HI+$ $

(595) &

(596)

(597) Year. Author (ref) Nr Pts Tracer. 123 1987

(598)

(599) 21 1999 Kang22 1271 207 2002 Schinkel23 929 2002 V20 2003 Berman24 5333 2004 Q

(600). &

(601) %

(602) 19 911 2998 2004 Miller25. 201TL 201TL,MIBI. MIBI 201TL,MIBI 201TL,MIBI 201TL,MIBI 201TL,MIBI. Stressor. {

(603)

(604) {

(605)

(606)

(607)

(608)

(609) {

(610)

(611)

(612)

(613) Adenosine {

(614)

(615)

(616)

(617) {

(618)

(619)

(620)

(621) $

(622)

(623). Abnormal MPI (%). Mean F/U (m). HE in ab- HE in normal normal MPI MPI (%/yr) (%/yr). 56 41 64 48 37-62 44-51 60. 36 24±8 49±29 36±18 27±9 24 70±42. 4.8 3.9-7.9 6.6* 5.0-6.4 4.7-9.0* 5.6-13.2 3.6-5.9. 1.3 1.2 0.7* 3.6-3.9 1.8-2.5 2.0-3.3 NA. ~7 ". &@$ {

(624) #

(625) ;

(626) @" " < H++

(627)

(628) @]]

(629) HI+ $

(630) " %%Z #

(631) 201TL, thallium-201 chloride. ∗

(632) .

(633) F $

(634) "

(635)

(636)

(637) ;

(638)

(639) '< $. &

(640) % $

(641) #

(642)

(643) ;U?)@*W)< "

(644) HI+

(645) %

(646) #

(647)

(648) 20, 22, 38 +

(649)

(650)

(651) $

(652) &

(653)

(654)

(655) "

(656)

(657) "

(658)

(659) %

(660)

(661) " $ $ symptoms and/or perceived clinical high risk. No details with regards to the type of dia

(662)

(663)

(664).

(665)

(666) &

(667)

(668) %

(669)

(670) . #

(671)

(672)

(673) $

(674) "

(675)

(676)

(677)

(678) ;

(679)

(680) '< &

(681) &

(682) $

(683) #

(684)

(685) of abnormal stress MPI and cardiac event rate.19, 25, 34, 37Z

(686) #

(687)

(688)

(689)

(690)

(691) $

(692)

(693)

(694) $

(695)

(696) #

(697) "$ $

(698) &

(699)

(700)

(701) %

(702) $ $

(703)

(704)

(705) &

(706)

(707)

(708) "

(709)

(710) "

(711) HI+ "

(712) $

(713)

(714) "

(715) %

(716) The mean prevalence of silent ischemia ranged from 26%-39%, although Miller et al

(717) $

(718) HI+*]) "$

(719) $ $

(720) 25 Because of the

(721) $

(722) #

(723)

(724) "

(725)

(726) & $

(727) "

(728)

(729)

(730)

(731)

(732)

(733)

(734) $

(735) #

(736)

(737) "

(738)

(739) $ $

(740) &

(741)

(742) .

(743)

(744)

(745)

(746)

(747) #

(748) $ $

(749) #

(750)

(751) #

(752)

(753)

(754) $

(755) "

(756) $ $

(757) &

(758)

(759)

(760). ;

(761) :

(762) '< 30, 31, 36, 40-42 In general, these studies showed a. &

(763) $

(764) #

(765)

(766) "

(767) : %%" =) '') &

(768) #

(769)

(770)

(771) &

(772)

(773) $ 6

(774)

(775)

(776)

(777) %

(778)

(779) %

(780) %

(781)

(782)

(783) % 6

(784)

(785)

(786) 23.

(787) 24. Author (ref). Nr Pts. Mean F/U (m) Tracer. Kang22 V20 !5% $ 38. 1271 929 1427. 24±8 36±18 70±42 201TL,MIBI. 201TL,MIBI. 201TL,MIBI. {

(788)

(789)

(790)

(791) {

(792)

(793)

(794)

(795) {

(796)

(797)

(798)

(799) $

(800)

(801). Stressor. 133. Prior37. 2005. 36±18 12-102 70±42 201TL,MIBI. MIBI 201TL,MIBI 201TL,MIBI. Janand31 Penfornis41 % 30 Cossson40

(802) 36 Anand42. 203 56 925 262 1123 510. 60 42±24 60 18±5 MIBI MIBI. 201TL. 201TL. 201TL. 201TL. {

(803)

(804) $

(805) {

(806)

(807) $

(808) {

(809)

(810) {

(811)

(812) $

(813) Adenosine {

(814)

(815) $

(816). {

(817)

(818) $

(819) {

(820)

(821)

(822)

(823) {

(824)

(825)

(826)

(827) $

(828)

(829) {

(830)

(831) $

(832). 19 21 6 16 22 13. 37. 26 39 59. 41 48 58. Abnormal MPI (%). NA. 2 1.6 NA. 1.2 3.6-3.9 1.6. NA NA NA NA 3.9# 0.44# 0.75 3.4 !

(833)

(834) $

(835)

(836) '((Y NA NA. NA. 9 3.4 NA. 3.9-7.9 5.0-6.4 5.9-3.6. HE with HE with abnormal normal MPI MPI (%/yr) (%/yr). ~7 ". &@${

(837) #

(838) R

(839) " " #= {

(840)

(841) %

(842) 6 %H++

(843)

(844) @]]

(845) HI+ $

(846) " %%201TL, thallium-201 chloride.. 1999 2001 2002 2004 2004 2005.

(847)

(848) . 180 826 1738.

(849)

(850) K 34 Q

(851). &

(852) %

(853) 19 Miller25. 2002 2004 2004.

(854)

(855) . 1999 2002 2005.

(856) . Year. Table 2. I

(857) #

(858)

(859) " HI+

(860) #

(861)

(862) $

(863) #

(864)

(865)

(866) $ $

(867) #

(868)

(869) $

(870) & type 2 diabetes mellitus.. Chapter 2.

(871) Screening for silent CAD.

(872) $

(873) #

(874) #

(875) $

(876) #

(877)

(878) "

(879) :

(880) $

(881)

(882) H

(883)

(884)

(885)

(886) ;H<$ $

(887) &

(888)

(889)

(890)

(891)

(892)

(893)

(894) %$

(895) F %

(896) 30 Only if this test was abnormal,

(897) HI+&$

(898) "

(899) + $

(900)

(901)

(902) "

(903)

(904) # "

(905)

(906)

(907)

(908)

(909) %$

(910) #

(911) .

(912) #

(913) $

(914) #

(915)

(916) "

(917) #

(918)

(919) :& &;=)< H

(920) #

(921) "

(922) #

(923)

(924) & &&

(925). @

(926)

(927)

(928)

(929) :

(930) performed either exercise electrocardiography or thallium-201 imaging, whereas Penfornis et al used exercise electrocardiography, stress MPI or stress echocardiography.31, 40, 41 :

(931) '$ $

(932) #

(933)

(934) $ $

(935) &

(936)

(937)

(938) . % % J

(939)

(940)

(941) "+

(942) $

(943) ;+< &

(944)

(945)

(946)

(947) ;

(948)

(949) @]]

(950) HI+<

(951) $

(952) "

(953) . *'' K

(954) $

(955) 36+

(956) + '') "$

(957) HI+

(958) +

(959)

(960) *?($ $

(961) &

(962)

(963) $

(964) @

(965)

(966) %$

(967) "

(968) %

(969)

(970) @

(971) :;{:< +"

(972) {:::

(973) &?((% %

(974)

(975) stress MPI was performed.43

(976) $

(977) $

(978) #

(979)

(980) "

(981) :

(982) & ?X)

(983)

(984) '

(985)

(986) $ $

(987) #

(988)

(989)

(990)

(991) $

(992) #

(993)

(994) "

(995) : $ $

(996)

(997) &

(998) &%%

(999)

(1000)

(1001) $

(1002) #

(1003)

(1004)

(1005)

(1006) "

(1007)

(1008) %

(1009) @

(1010) 6

(1011) #

(1012)

(1013) F& ,

(1014) .

(1015) %

(1016) $ $ "$ $

(1017) &

(1018)

(1019) .

(1020)

(1021)

(1022) :

(1023) 3

(1024) ;{:

(1025) :<. &" ##

(1026)

(1027)

(1028) 3F " ::

(1029)

(1030) ": 44

(1031) #

(1032)

(1033)

(1034)

(1035)

(1036)

(1037) $ % %F

(1038) "::

(1039)

(1040) %

(1041)

(1042) $ $ 45-48 Because of the previously

(1043)

(1044)

(1045) &

(1046)

(1047) :

(1048)

(1049)

(1050).

(1051) $

(1052) #

(1053)

(1054) " ::

(1055)

(1056)

(1057) $

(1058) $

(1059) &

(1060)

(1061) & &: 49 In a cohort study " X( ](U $ # % ? (Y*

(1062)

(1063)

(1064) ::

(1065) & %

(1066)

(1067) %

(1068) $

(1069) &

(1070)

(1071) $

(1072) &

(1073)

(1074) +

(1075)

(1076) " #% ::

(1077)

(1078) %

(1079) %

(1080) ~%

(1081)

(1082) 3

(1083) & Y()%

(1084)

(1085) " $

(1086) &

(1087)

(1088) !%%

(1089) #

(1090) %

(1091)

(1092) $ % #

(1093) " CAC in subjects with and without diabetes mellitus.50 In a cohort of 10,377 asymptom# &

(1094) ](X

(1095)

(1096)

(1097) ::

(1098)

(1099)

(1100) &

(1101)

(1102) %F %

(1103) 5

(1104) &

(1105)

(1106)

(1107) &

(1108)

(1109) H

(1110) #

(1111) "

(1112) #

(1113)

(1114)

(1115) ::

(1116)

(1117)

(1118) &%

(1119)

(1120)

(1121)

(1122) "

(1123) 25.

(1124) Chapter 2. $

(1125) " $

(1126) &

(1127)

(1128) + $

(1129) &

(1130)

(1131) evidence of CAC had a similar survival compared to that of individuals without diabetes and no detectable CAC. Qu et al noted that subjects with diabetes and low CAC score had " @"

(1132)

(1133)

(1134) #

(1135)

(1136) $

(1137) &

(1138) 5

(1139) & a low CAC score.51J

(1140)

(1141)

(1142) $ % #

(1143) ":: & &

(1144)

(1145) $

(1146) &

(1147)

(1148) $

(1149) &

(1150)

(1151) {

(1152)

(1153)

(1154) "

(1155)

(1156) $

(1157) &

(1158)

(1159) & @$ $

(1160)

(1161) and CAC score.52 Thus, CAC scoring may be linked to the metabolic syndrome in type 2

(1162) +$ # H

(1163)

(1164)

(1165)

(1166) $

(1167) #

(1168)

(1169) "::& %F

(1170)

(1171) &

(1172)

(1173) X" &

(1174)

(1175) $

(1176)

No results found